10-Q quarterly report · filed Nov 2, 2026

Idexx Laboratories (IDXX) Q3 2026 10-Q Quarterly Report

Short answer

Idexx Laboratories (IDXX) filed its Q3 2026 10-Q quarterly report on Nov 2, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $1.2B (up 9.9% year over year) with net income of $317M.

Q3 2026 key financials · XBRL

Revenue
$1.2B
+9.9% YoY · −0.2% QoQ
Net income
$317M
+15.5% YoY · −6.3% QoQ
Operating margin
33.1%
Gross margin
62.9%
EPS (diluted)
$4.01
+17.9% YoY · −6.1% QoQ

Source: XBRL data from the Idexx Laboratories (IDXX) Q3 2026 10-Q on SEC EDGAR. USD.

Idexx Laboratories Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $1.214B, up 9.9% YoY from $1.105B
  • Operating margin 33.1% vs 32.1%; gross margin 62.9% vs 61.8%
  • Best segment CAG: revenue $1.116B, up 10.2%; worst LPD: $34.8M, up 2.6%
  • Operating cash flow $1.063B, up from $826.0M; cash $197.5M vs $180.1M
  • 2026 capital expenditure plan approximately $160.0M; tariff, inflation, freight and supply-chain headwinds cited

Risk Factors

  • No material changes from 2025 Annual Report risk factors
  • Unknown or currently immaterial risks could materially adversely affect business, financial condition, or future results

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Idexx Laboratories quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.